Makeup Base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin is listed as a humectant in this development reference. The recorded formula also lists Aqua (Water) and Squalane. Review moisture feel and tack in the complete formula.

3. Typical use levels (formulation guide)

• The formulation record gives 5% w/w as the component allocation.

Add Glycerin in the water phase without melting it first.

4. Regulatory sources & global compliance

• The listed information is intended as a development reference; it does not approve the supplied grade or finished product; This is not authorization of a product as sold.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; it should not be read as a drug authorization or OTC listing and the completed formula still requires stability and patch testing.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; consider an airless or pump format when oxidation sensitivity warrants it; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The cosmetic role of Glycerin is presented as humectant function.

• The available ingredient details does not support drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The documented facts for Glycerin does not establish skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane is listed as an emollient in this development reference. The recorded formula also lists Aqua (Water) and Glycerin. Review spreading, slip and the finish of the complete formula.

3. Typical use levels (formulation guide)

• Reference component allocation: 3% w/w.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• The card records a development guide; it is not a product authorization or an approval of supplier grade; The note should not be read as approval of the final formula.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it does not establish drug approval or OTC-monograph status so assess patch response and stability in the final formula.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; where oxidation is a concern, evaluate airless or pump packaging; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• The development record is not evidence of therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The formulation record for Squalane should not be used to substantiate a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.